Translate AMICOR contents if you like

Friday, March 03, 2017

Iron & Aortic Stenosis

Iron Alters Valvular Interstitial Cell Function and Is Associated With Calcification in Aortic Stenosis

Andres Laguna-Fernandez; Miguel Carracedo; Gregoire Jeanson; Edit Nagy; Per Eriksson; Giuseppina Caligiuri; Anders Franco-Cereceda; Magnus Bäck
Eur Heart J. 2016;37(47):3532-3535. 

Abstract and Introduction


Aims Aortic valve stenosis (AS) is the most common valvulopathy and is characterized by inflammation, extracellular matrix (ECM) remodelling and calcification, causing a narrowing of the valve and the consequential obstruction of the cardiac outflow. Although intraleaflet haemorrhage is associated with AS progression, the mechanisms involved are not known. The aims of this study were to identify valvular iron in relation to pathological changes associated with AS and the effects on valvular interstitial cells (VIC) in terms of iron uptake and iron-induced responses.
Methods and results Valvular iron accumulation was detected by Perls' staining on aortic valve sections and shown to increase with the extent of calcification. Furthermore, qRT–PCR analysis revealed that iron-containing valve regions exhibited increased expression of genes involved in ECM remodelling and calcification. In addition, we demonstrate that iron transporters are regulated by pathways with major impact on AS and that VIC can take up and accumulate iron, which resulted in increased proliferation and decreased elastin production.
Conclusion Iron, which may accumulate in the aortic valve by means of intraleaflet haemorrhages, can be taken up by VIC in a pro-inflammatory environment and actively contribute to VIC proliferation, ECM remodelling and calcification. These findings suggest a possible mechanism through which iron uptake by VIC may favour AS progression.

No comments: